Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.7239
Delayed Data
As of 3:59pm ET
 -0.0351 / -4.62%
Today’s Change
0.39
Today|||52-Week Range
4.89
-75.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2009
Quarter 2
2009
Quarter 3
2009
Quarter 4
2009
Revenue and IncomeOther Operating Income----19.2K--
 
 
Net Revenues0.000.0019.2K0.00
 
 
Cost of Goods Sold0.000.00103.0K0.00
 
 
Depreciation And Amortization894.00894.00894.00930.00
 
 
 
 
 
 
Operating ExpensesGross Income-894.00-894.00-84.7K-930.00
 
 
 
 
 
Other Operating Expenses404.0K338.9K298.1K577.8K
 
 
 
 
 
Total Operating Expenses404.9K339.8K402.0K578.8K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-404.9K-339.8K-382.8K-578.8K
 
 
 
 
 
Extraordinary Charge0.000.000.00-80.0K
 
 
Interest Expense On Debt0.000.000.002.4K
 
 
Interest Expense Total------2.4K
 
 
Other Expenses37.0K21.3K0.00181.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-368.0K-318.5K-382.8K-480.1K
 
 
 
 
 
Discontinued Operations-130.3K0.000.000.00
 
 
Extraordinary Items1.2M0.000.000.00
 
 
Net Income-498.3K-318.5K-382.8K-480.1K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.7M3.7M3.7M3.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.7M3.7M3.7M3.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.08-$0.10-$0.12
 
 
 
 
 
EPS Diluted-$0.14-$0.08-$0.10-$0.12